Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors

Transplantation

Volumn 65, Issue 12, 1998, Pages 1584-1590

  Zaidi, Afzal ^a,b   Schmoeckel, Michael ^a,b   Bhatti, Farah ^a,b   Waterworth, Paul ^a,b   Tolan, Michael ^a,b   Cozzi, Emanuele ^a,c   Chavez, Gilda ^a   Langford, Gillian ^a   Thiru, Sathia ^c   Wallwork, John ^b   White, David ^c   Friend, Peter ^c  

^a Imutran Ltd   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL SURVIVAL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GENETICS; HISTOCOMPATIBILITY; KIDNEY TRANSPLANTATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODY FORMATION; ANTIGENS, CD55; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; ERYTHROCYTES; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032572281     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199806270-00008     Document Type: Article

References (43)

1. Cooper DKC, Ye Y, Rolf JLL, Zuhdi N. The pig as a potential organ donor for man. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation: the transplantation of organs and tissues between species. Berlin: Springer-Verlag, 1991: 481.
2. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
3. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
4. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 52: 530.
5. Hourcade D, Holers VM, Atkinson JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989; 45: 381.
6. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26: 1400.
7. Yannoutsos N, Langford GA, Cozzi E, et al. Production of pigs transgenic for human regulators of complement activation. Transplant Proc 1995; 27: 324.
8. White DJG, Langford GA, Cozzi E, Young VK. Production of pigs transgenic for human DAF: a strategy for xenotransplantation. Xenotransplantation 1995; 2: 213.
9. Waterworth PD, Cozzi E, Tolan M, et al. Pig-to-primate cardiac Xenotransplantation and cyclophosphamide therapy. Transplant Proc 1997; 29: 899.
10. Kuipers HW, Langford GA, White DJG. Analysis of transgene integration sites in transgenic pigs by fluorescence in situ hybridisation. Transgenic Res 1997; 6: 253.
11. Cozzi E, Langford GA, Richards A, et al. Expression of human decay accelerating factor in transgenic pigs. Transplant Proc 1994; 26: 1402.
12. Rosengard A, Cary NRB, Langford GA, Tucker AW, Wallwork J, White DJG. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs: a potential approach for preventing xenograft rejection. Transplantation 1995; 59: 1325.
13. Platt JL, Lindman BJ, Chen H, Spitalnik SL, Bach FH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation 1990; 50: 817.
14. Starzl TE, Marchioro TL, Peters GN, et al. Renal heterotransplantation from baboon to man: experience with six cases. Transplantation 1964; 2: 752.
15. Hitchcock CR, Kiser JC, Telander RL, Seljescog EL. Baboon renal grafts. JAMA 1964; 189: 934.
16. Ogden DA, Sitprija V, Holmes JH. Function of the baboon renal heterograft in man and comparison of renal homograft function. J Lab Clin Med 1965; 65: 370.
17. Reemtsma K, McCracken B, Schlegel J, et al. Renal heterotransplantation in man. Ann Surg 1964; 160: 384.
18. Gianello PR, Latinne D, Alexandre GPJ. Pig-to-baboon renal xenografts. Xeno 1995; 3(2): 26.
19. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanism of complement activation in the hyper-acute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
20. Leventhal JR, John R, Fryer JP, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Transplantation 1995; 59: 294.
21. Kroshus TJ, Bolman RM, Dalmasso AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996; 62: 5.
22. Cooper DKC, Ye Y, Niekrasz M, et al. Specific intravenous carbohydrate therapy. Transplantation 1993; 56: 769.
23. Miyazawa H, Murase N, Demetris A, et al. Hamster to rat kidney xenotransplantation. Transplantation 1995; 59: 1183.
24. Fischel RJ, Matas AJ, Platt JL, et al. Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival. J Heart Lung Transplant 1992; 11: 965.
25. Hammer C, Suckfull M, Saumweber D. Evolutionary and immunological aspects of xenotransplantation. Transplant Proc 1992; 24: 2397.
26. Sandrin MS, Fodor WL, Cohney S, et al. Reduction of the major porcine xenoantigen galα(1,3)gal by expression of α(1,2)fucosyltransferase. Xenotransplantation 1996; 3: 134.
27. Sharma A, Okabe J, Birch P, et al. Reduction in the level of gal(α1,3)gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190.
28. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
29. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
30. Pruitt SK, Bollinger RR, Collins BH, et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 1997; 63: 900.
31. Davis EA, Pruitt SK, Greene PS, et al. Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts. Transplantation 1996; 62: 1018.
32. White DJG, Langford GA, Cozzi E, Young VJ. Protective effects of human DAF in transgenic pigs. Xeno 1995; 3(3): 48.
33. Atkinson JP, Oglesby TJ, White DJG, Adams EA, Liszewski MK. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor. Clin Exp Immunol 1991; 86 (suppl 1): 27.
34. Post TW, Acre MA, Liszewski MK, Thompson ES, Atkinson JP, Lublin DM. Structure of the gene for human complement protein decay accelerating factor. J Immunol 1990; 144: 740.
35. Auchincloss H. Xenogeneic transplantation. Transplantation 1988; 46: 1.
36. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
37. Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity: characterising and avoiding the problem. Drugs 1991; 42: 781.
38. Yasunaga C, Cramer D, Cosenza C, et al. Effect of brequinar sodium on in vivo antibody production. Transplant Proc 1993; 25 (3 suppl 2): 40.
39. Morikawa K, Oseko F, Morikawa S. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells. Transplantation 1992; 54: 526.
40. Ulrichs K, Kaitschick J, Bartlett R, Muller-Ruchholtz W. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide. Transplant Proc 1992; 24: 718.
41. Sollinger H. Mycophenolate mofetil. Kidney Int 1995; 48 (suppl 52): 14.
42. Segal SN. Rapamune (sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit 1995; 17: 660.
43. Murase N, Starzl T, Demetris A, et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55: 701.